
|Articles|April 7, 2023
Pharma USA 2023: Changes to the Medical Affairs Function
Sunil Verma, SVP, Global Head of Oncology, Medical, AstraZeneca discusses how the Medical Affairs role will become more strategic and effective with data.
Advertisement
Sunil Verma, MD, SVP, Global Head of Oncology, Medical, AstraZeneca recently presented at Pharma USA 2023 on the topic, "The beginning of a new Medical, the end of an Affair." In this video, Dr. Verma tells PharmExec about how the role of medical affairs will positively influence patient outcomes and the standard of care with the use of data.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Elicio Therapeutics’ Shares Drop Following Announcement of Phase II Trial Results
2
Partnering in Non-Opioids: Q&A with Dr. Edward Littler and Dave Watson
3
Novavax's Strategy Across Commercial, R&D, and Partnerships
4
Pharma Roundup: FDA Approves Truqap Plus Abiraterone and Prednisone, FDA Approves Keytruda and Keytruda Qlex Each in Combination with Welireg
5




